My Shopping Cart
 
There are no items in your shopping cart.


Avoiding 483's Throughout Your Organization - Strategies, Risk and Mitigating Approaches (CPG187F)

Presented by: Charles H. Paul
 
Request Replay Date:
(*) Single User Price. For multiple users please call 1-800-223-8720
Pre Recorded Webinar
60 minutes
  •  Thu, January 25, 2018
Event Description

Learn to Develop a Compliance Program Specific to Your Organization for Avoiding 483s

483s can occur in any life science organization. FDA audits often lead to form 483s; they are issued the primarily for not meeting the regulatory requirements in practice. While some 483 audits are resolved amicably; some cases have serious consequences for the concerned organization, ranging from receiving warning letters to paying heavy fines. The costs and implications to the company can be staggering. The cost of a 483 is significant but unique to each company. In general, the cost includes – reputation damage, competitor leverage, loss of business, lost stockholder confidence, and diversion from the job at hand, none of which a life sciences company can afford in today’s competitive environment.

Unfortunately, most regulated industries don’t have a set approach for developing a compliance program that is integrated into the fabric of their organization with the goal of avoiding 483s and which serves real valuable functions, such as: improving operations, improving and maintaining human competence, and enhancing competitiveness. Compliance and regulatory affairs are viewed in many cases as a “non-value add,” which is an expense and not an asset; it is a “check-the-box” to be completed in the event of a regulatory audit or issue and because it is required.

Your organization must create a compliance program that helps you avoid 483s. You must standardize your operations and build your operations around safety and efficacy. You must structure an organization that exceeds your regulatory responsibilities, while at the same time, optimizing every function within the company that the regulatory processes touch. Avoiding 483’s and adverse findings, if the strategies are executed properly, will also significantly contribute to achieving operational excellence. The most simplistic solution to achieving compliance excellence and avoiding 483s is “to do the right things right!” However, what does it really mean?

Join this session with regulatory compliance expert Charles H. Paul, who has distilled the “doing the right things right” solution into 7 separate individual keys or actions that will provide a solid foundation for the establishment of any 483 avoidance program. In this session, Charles will provide you with the strategies for not only avoiding 483s, but also for improving all facets of your company’s operations.

Charles will discuss the approach and framework that you need to follow to make your compliance program a valuable ingredient in the process of running your business. This session provides the significant benefit of avoiding 483s and other adverse regulatory reporting, while at the same time, achieving a measure of operational excellence.

Session Highlights

This session will help you understand:

  • The regulations that pertain to your industry and your business throughout each level and function of your organization
  • The critical processes and why they are important
  • The benefits of developing sound regulatory documentation
  • Why harmonizing your processes is critical to consistency in operations and regulatory compliance
  • Why technical training is essential to every aspect of business operations to meet and exceed regulating requirements
  • How to institute a sound and effective complaint and investigations handling process
  • Performance management – the glue that holds everything together and guarantees acceptable performance throughout the organization

Who Should Attend

This session is applicable to the entire life sciences industry, for:

  • Associates
  • Managers
  • Directors
  • Vice presidents
  • Quality assurance associates
  • Operations personnel
  • Operations managers and directors
  • Compliance managers and directors
  • Training managers and directors
  • Quality assurance managers and directors
About Our Speaker(s)

Charles H. Paul
Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm. Charles is a management consultant, instructional designer and regulatory consultant and has led C. H. Paul Consulting, Inc. since its inception over 25 years ago. He regularly consul... More info

 
Recommend this event to a colleague
  • Your Name:
  • Your E-mail:
  • Colleague's Name:
  • Colleague's E-mail:
  •  
    Event Title: Avoiding 483's Throughout Your Organization - Strategies, Risk and Mitigating Approaches
    Presenter(s): Charles H. Paul

 
 
 
Our Accreditation Partners
DMCA.com Protection Status